Trial Profile
Effects of New Longacting Insulin Analogs on Metabolic Control, Endogenous Insulin Production, GH/IGF-I Axis and Quality of Life - Comparison of NPH, Glargine Och Detemir Insulin From the Debut of Type 1 Diabetes Mellitus in Adolescents.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Insulin glargine (Primary) ; Insulin suspension isophane (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Jan 2011 New trial record